All News

Bristol-Myers Squibb Announces Intention to Voluntarily Delist Preferred Stock BUSINESS WIRE

Bristol-Myers Squibb to Hold Investor Teleconference to Discuss ASCO Highlights BUSINESS WIRE

Bristol-Myers Squibb Advances Leadership Position in Immuno-Oncology with Data to be Presented at 2013 American Society of Clinical Oncology (ASCO) Annual Meeting BUSINESS WIRE

Bristol-Myers Squibb to Present at UBS Global Health Care Conference BUSINESS WIRE

Bristol-Myers Squibb to Present at Bank of America Merrill Lynch Health Care Conference BUSINESS WIRE

Bristol-Myers Squibb and Pfizer Announce Publication of ARISTOTLE Subanalysis in Circulation BUSINESS WIRE

Sub-Group Analysis Shows Investigational Metreleptin Treatment Demonstrated Reductions in HbA1c, Triglycerides and Liver Function Tests in Pediatric Patients with Lipodystrophy During a 12-Month Period BUSINESS WIRE

Bristol-Myers Squibb Receives US FDA sNDA Approval for Use of SUSTIVA® (efavirenz) in HIV-1 Infected Pediatric Patients BUSINESS WIRE

Bristol-Myers Squibb Reports First Quarter 2013 Financial Results BUSINESS WIRE